These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 28350574)

  • 1. Recurrent Hyperammonemia Associated With Olanzapine.
    Wu YF
    J Clin Psychopharmacol; 2017 Jun; 37(3):366-367. PubMed ID: 28350574
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment-resistant schizophrenia: Neutropenia with olanzapine and clozapine, and stabilization with two depot antipsychotics].
    Alba P
    Vertex; 2017 Mar; 28(132):141-144. PubMed ID: 29522636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Case of Olanzapine-Induced Fever.
    Yang CH; Chen YY
    Psychopharmacol Bull; 2017 Jan; 47(1):45-47. PubMed ID: 28138204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sleepwalking Is Associated With Coadministration of Olanzapine and Propranolol: A Case Report.
    Deng S; Hu J; Zhu X; Shang D; Wen Y; Qiu C
    J Clin Psychopharmacol; 2017 Oct; 37(5):622-623. PubMed ID: 28719423
    [No Abstract]   [Full Text] [Related]  

  • 5. Dorsal hand skin hyperpigmentation following oral olanzapine (Zyprexa) use.
    Cary JH; Li BS; Maibach HI
    Contact Dermatitis; 2018 Oct; 79(4):254-255. PubMed ID: 30079483
    [No Abstract]   [Full Text] [Related]  

  • 6. Role of 5HT1A and 5HT2A receptors and default mode network in olanzapine-induced somnambulism.
    Das S; Gupta R; Dhyani M; Sah D; Maity J
    Neurol India; 2017; 65(2):373-374. PubMed ID: 28290400
    [No Abstract]   [Full Text] [Related]  

  • 7. Case report: Olanzapine post-injection delirium/sedation syndrome mimicking brainstem-thrombosis.
    Pollentier A; Vergaelen M; De Bleecker JL
    Acta Neurol Belg; 2021 Oct; 121(5):1383-1384. PubMed ID: 34009531
    [No Abstract]   [Full Text] [Related]  

  • 8. Late-Onset Cholestatic Liver Injury During Combination Treatment With Chlorpromazine and Olanzapine: A Case Report.
    Dusi N; Comacchio C; Lasalvia A
    J Clin Psychopharmacol; 2019; 39(2):175-176. PubMed ID: 30640795
    [No Abstract]   [Full Text] [Related]  

  • 9. Olanzapine-Associated Portal and Superior Mesenteric Vein Thrombosis.
    Mameli A; Natale L; Musu M; Finco G; Pisanu A; Marongiu F; Barcellona D
    Am J Ther; 2020; 27(4):e419-e420. PubMed ID: 31033495
    [No Abstract]   [Full Text] [Related]  

  • 10. Olanzapine-Induced Fever.
    Ferreira TF; Godinho FDG; Dehanov SD; Trancas B; Maia T
    Prim Care Companion CNS Disord; 2019 Feb; 21(1):. PubMed ID: 30817864
    [No Abstract]   [Full Text] [Related]  

  • 11. Early prediction of olanzapine-induced weight gain for schizophrenia patients.
    Lin CH; Lin SC; Huang YH; Wang FC; Huang CJ
    Psychiatry Res; 2018 May; 263():207-211. PubMed ID: 29574355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclosporine-Olanzapine Drug-Drug Interaction.
    Robles-Martínez M; Monge MF; Iglesias-González M
    Prim Care Companion CNS Disord; 2018 Apr; 20(2):. PubMed ID: 29701931
    [No Abstract]   [Full Text] [Related]  

  • 13. Worsening of Myasthenia Gravis After Administration of Antipsychotics for Treatment of Schizophrenia: A Case Report and Review of Literature.
    She S; Yi W; Zhang B; Zheng Y
    J Clin Psychopharmacol; 2017 Oct; 37(5):620-622. PubMed ID: 28640071
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of olanzapine on resting heart rate in Japanese patients with schizophrenia.
    Tajiri M; Suzuki Y; Sugai T; Tsuneyama N; Someya T
    PLoS One; 2018; 13(7):e0199922. PubMed ID: 30016331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delayed Onset Postinjection Delirium/Sedation Syndrome Associated With Olanzapine Pamoate: A Case Report.
    Garg S; Gupta D; Rakesh K; Tikka SK
    J Clin Psychopharmacol; 2019; 39(5):523-524. PubMed ID: 31433337
    [No Abstract]   [Full Text] [Related]  

  • 16. An unusual bullous eruption: olanzapine induced pseudoporphyria.
    Johnson OR; Stewart MF; Bakshi A; Weston P
    BMJ Case Rep; 2019 Nov; 12(11):. PubMed ID: 31678928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical consequences of switching antipsychotic drugs in outpatients with schizophrenia: 36-month results from the European Schizophrenia Outpatient Health Outcomes study.
    Novick D; Haro JM; Suarez D; Marques-Teixeira J; Naber D
    Int Clin Psychopharmacol; 2008 Jul; 23(4):203-8. PubMed ID: 18545058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute Necrotizing Pancreatitis Associated With Orally Disintegrating Formulation of Olanzapine: Implications on Clinical Presentation and Management.
    Vaidyanathan S; Subramanian K; Bharadwaj B; Das S; Kola GST; Maroju NK
    J Clin Psychopharmacol; 2019; 39(5):519-521. PubMed ID: 31433336
    [No Abstract]   [Full Text] [Related]  

  • 19. [A naturalistic, observational study of outpatients with schizophrenia: efficacy and safety results after 6 months. The International Schizophrenia Outpatient Health Outcomes study, IC-SOHO].
    István S; Agoston T; Tamás T; Zoltán J
    Neuropsychopharmacol Hung; 2007 Oct; 9(3):115-24. PubMed ID: 18399029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Unexpected Case of Diabetic Ketoacidosis on the Psychiatry Ward: Olanzapine-Associated Adult Ketosis-Prone Type 2 Diabetes Mellitus.
    Tugwell BD; King DS; Kaiser SM
    Can J Diabetes; 2020 Apr; 44(3):216-218. PubMed ID: 31494032
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.